Results 121 to 130 of about 16,580 (214)

Endothelial Cells Offer a Better Option than Smooth Muscle Cells for the Treatment of Ischemic Limb Disease. [PDF]

Cells
Green A, Zhang H, Bo B, Guragain B, Wu Y, Wei Y, Zhang J, Ye L.   +7 more
europepmc   +1 more source

Higher plasma vitamin D levels are not causally associated with less age‐related macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose Higher levels of plasma 25‐hydroxyvitamin D have been associated with a lower risk of age‐related macular degeneration (AMD). We investigated observational and potential causal associations of plasma 25‐hydroxyvitamin D with the risk of AMD in two large contemporary population‐based prospective studies and a genetic case–control ...
Sabina O. Beheshti, Michael Larsen, Børge G. Nordestgaard, Shoaib Afzal   +3 more
wiley   +1 more source

External Venous Drainage (EVD) System: A Standardized Bedside Technique for Venous Congestion in Free Flaps. [PDF]

Clin Case Rep
Marcasciano M, Nanni J, Chang C, Firmani G, Farid Y, Rodríguez-Mantilla IE, Sorkin A, Chen HC.   +7 more
europepmc   +1 more source

Occurrence, progression and risk factors of macular atrophy in neovascular age‐related macular degeneration according to neovascularization subtypes

Acta Ophthalmologica, EarlyView.
Abstract Objective To assess the occurrence, risk factors, and progression of macular atrophy (MA) according to macular neovascularization (MNV) subtype in neovascular AMD (nAMD). Methods This multicentre retrospective observational cohort study included 416 eyes with nAMD, followed for at least 12 months and treated with anti‐VEGF.
Amandine Moulin, Geoffrey Zeender, Pauline Rizzuto, Pierre Gascon, Kevin Allaix, Audrey Feldman, Flore De Bats, Benjamin Wolff, Pierre Pradat, Philippe Desmangles, Laurent Kodjikian, Thibaud Mathis   +11 more
wiley   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists and Ocular Outcomes: Metabolic Transition, Retinal Vulnerability, and Risk-Stratified Monitoring. [PDF]

J Obes Metab Syndr
Song SJ, Kim E.
europepmc   +1 more source

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source

Hemolytic Glaucoma Following Intravitreal Aflibercept Injection for Age-Related Macular Degeneration: A Case Report. [PDF]

Am J Case Rep
Sano H, Yanai R, Mitamura Y.
europepmc   +1 more source

The road ahead for stem cell therapies in type 1 diabetes

Diabetic Medicine, EarlyView.
Abstract Aims Type 1 diabetes results from autoimmune destruction of insulin‐producing pancreatic β‐cells. Although exogenous insulin remains the standard treatment, it does not restore physiological glucose regulation. Differentiation of human pluripotent stem cells into β‐cells offers a scalable alternative to cadaveric islet transplantation and has ...
Rosa Gasa, Rocio Sancho, Francesca M. Spagnoli   +2 more
wiley   +1 more source

Expanding horizons of intravitreal anti-vascular endothelial growth factor therapy in retinal diseases. [PDF]

Indian J Ophthalmol
Singh S, Kala U, Bamel A, Agarwal M.
europepmc   +1 more source

USP25 promotes ferroptosis in diabetic retinopathy by deubiquitinating p53 and suppressing the GPX4/SLC7A11 axis

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Objective To explore the expression of the deubiquitinase (DUB) USP25 in diabetic retinopathy (DR) and its mechanistic role in regulating ferroptosis. Methods Bioinformatics was used to screen for DR‐related DUB candidate genes. USP25 expression was validated in a streptozotocin‐induced diabetic mouse model and high glucose (HG)‐treated ARPE ...
Yanjun Gao, Wenjing Zhao, Qiannan Chai, Cunxi Ye   +3 more
wiley   +1 more source